Improving patient outcomes through advanced pain management techniques in total hip and knee arthroplasty.

John W. Barrington, David F. Dalury, Roger H. Emerson, Richard J. Hawkins, Girish P. Joshi, Bernard N. Stulberg

Research output: Contribution to journalArticlepeer-review

46 Scopus citations


Pain following orthopedic surgery is common and often suboptimally managed, with many patients reporting acute moderate to severe pain following surgery. Opioids are often used to manage this pain, yet this can result in significant side effects and complications, including constipation, nausea, vomiting, respiratory distress, and other central nervous system issues. Multimodal therapy that includes surgical site infiltration with extended release local anesthetic has been seen as a new way to minimize this pain for patients, which can result in improved quality of life and shorter length of hospital stay. This article examines the use of bupivacaine liposome injectable suspension (EXPAREL®; Pacira Pharmaceuticals, Inc., San Diego, California), a non-opioid product for pain management. Liposomal bupivacaine uses DepoFoam® technology that allows for the extended release of injected drugs. When used as the foundation of a multimodal regimen, it is effective in reducing postsurgical pain for up to 72 hours while reducing the need for opioids for pain relief.

Original languageEnglish (US)
Pages (from-to)S1-S20
JournalAmerican journal of orthopedics (Belle Mead, N.J.)
Issue number10 Suppl
StatePublished - Oct 2013

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Improving patient outcomes through advanced pain management techniques in total hip and knee arthroplasty.'. Together they form a unique fingerprint.

Cite this